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STUDY ON VETERINARY STEM CELLS 
 ADVANCES AND APPLICATIONS 
INTRODUCTION	  
WHAT	  ARE	  STEM	  CELLS?	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Regenera've	  medicine	   refers	   to	   therapies	   that	   seek	   to	   restore	   the	   form	   and	   func'on	   of	  
normal	  cells	  using	  the	  body's	  own	  biological	  machinery,	  as	  are	  stem	  cells.	  	  
Since	  the	  ﬁrst	  study	  succeeded	  in	  achieving	  pluripotent	  stem	  cells	   in	  1981,	  the	  aim	  of	  the	  
research	   has	   been	   changing	   diversely,	   from	  preclinical	  model	   in	   experimental	   studies	   for	  
human	  diseases	  to	  clinical	  therapeu'c	  applica'ons	  in	  animals.	  	  	  
x	  
AIM	  OF	  THE	  STUDY	  
Stem	   cells	   are	   func'onally	   deﬁned	  
as	  cells	  with:	  
•  Capacity	  to	  self-­‐renewal	  
•  Ability	   to	  generate	  diﬀerenBated	  
cells	  
Maintained	   indeﬁnitely	   in	   culture	  
and	  s'll	  maintain	  the	  competence	  to	  
produce	  cells	  in	  a	  foetus.	  	  
	  
•  Discover	  the	  basics	  of	  regenera've	  therapies.	  	  
•  BeIer	  understand	  stem	  cells	  and	  its	  types.	  	  
•  Observe	   the	   progress	   made	   in	   therapeu'c	  
applica'ons	  in	  veterinary	  medicine	  so	  far.	  	  
CLASSIFICATION	  	  
According	  to	  their	  ability	  to	  diﬀeren'ate:	  
•  Pluripotent:	   embryonic	   stem	   cells	   (ESCs)	   and	   induced	  
pluripotent	  cells	  (iPSCs).	  
	  	  	  	   	  	  
•  MulBpotent:	  mesenchymal	  adult	  soma'c	  cells	  (ASCs).	  	  
	  
	  
The	  stage	  of	  development	  where	  they	  are	  obtained:	  
•  Embryonic	  stem	  cells	  	  	  	  	  	  	  	  	  	  	  	  	  inner	  cell	  mass	  of	  the	  blastocyst.	  
•  Adult	  somaBc	  stem	  cells	  	  	  	  	  	  	  	  	  	  	  	  	  'ssue	  lineages.	  
	   	   	   	   	   	   	   	   	   (endoderm,	   mesoderm	   and	   ectoderm)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
























Building	  human	  organs	  in	  
domes'c	  animals	  
Development	  of	  biomarkers,	  
drug	  and	  toxicity	  detec'on	  
Deriva'on	  of	  gametes	  
and/or	  embrios	  
Basic	  research	  	  
Figure	  2.	  Poten'al	  applica'ons	  of	  adult	  stem	  cells	  from	  adipose	  'ssue.	  
Figure	  3.	  Poten'al	  applica'ons	  of	  induced	  pluripotent	  stem	  cells	  (A.	  Cebrian-­‐Serrano	  et	  al.,	  2013).	  
Figure	  1.	  Stem	  cell	  classiﬁca'on	  (Whitworth	  i	  Banks,	  2014).	  	  
Principally:	  
•  Osteoarthri's	  
•  Tendini's	  	  
	  
STEM	  CELL	  APPLICATIONS	   	  
COMPARISION	  BETWEEN	  STEM	  CELL	  TYPES	   	  
ESCs	   ASCs	   iPSCs	  
Derived	  from	  the	  inner	  cell	  
mass	  of	  the	  blastocyst	  
Come	  mainly	  from	  bone	  marrow	  or	  
adipose	  'ssue	  
Come	  from	  reprogramming	  
of	  soma'c	  cells	  
Pluripotent	   Mul'potent	   Pluripotent	  
Allogenic	   Autologous	   Autologous	  
No	  clinical	  applica'ons	   There	  are	  clinical	  applica'ons	  
	  (main	  source	  of	  actual	  therapies)	  
S'll	  clinical	  applica'ons	  in	  
study	  	  
Risk	  of	  teratomas	  and	  
teratocarcinoma	  
Slight	  tumorigenic	  risk	  	   Risk	  of	  teratomas	  
Table	  1.	  Features	  of	  diﬀerent	  stem	  cell	  types.	  	  	  
Figure	  4.	  Obtaining	  ESCs	  (Na'onal	  Academies,	  2010)	   Figure	  5.	  Obtaining	  iPSCs	  (Gene'c	  Sciene	  Learning	  Center,	  2016)	  
CONCLUSIONS	  
•  Advances	  in	  studies	  in	  veterinary	  medicine	  have	  opened	  a	  wide	  range	  of	  opportuni'es	  for	  regenera've	  medicine	  therapies.	  
	  	  	  	  	  	  	  	  	  	  However	  the	  studies	  do	  not	  follow	  the	  standards	  or	  protocols	  
Its	  reliability	  is	  ques'onable	  and	  may	  jeopardize	  the	  reputaBon	  of	  the	  ﬁeld.	  
•  Most	  applica'ons	  today	  are	  for	  musculoskeletal	  diseases,	  but	  gradually	  new	  doors	  are	  being	  opened	  for	  other	  diseases	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Cardiac	  or	  hepa'c	  disorders,	  diabetes,	  transplants..	  
• When	  regenera've	  medicine	  is	  well-­‐deﬁned	  it	  will	  give	  tools	  for	  new	  therapeu'c	  approaches	  and	  to	  improve	  the	  research	  in	  human	  medicine.	  
give	  rise	  to	  all	  the	  'ssues	  of	  the	  body	  
	  replenish	  cells	  within	  speciﬁc	  organs	  or	  'ssues	  
